Monitoring
of Theophylline Treatment
Theophylline is a potent xanthine derivative used as a barometrically
in the treatment of asthma and chronic obstructive pulmonary disease (COPD). The drug has
a very narrow therapeutic margin; Therapeutic plasma concentrations range from 10 to 20
ug/mL with severe toxicities associated with higher concentrations. Fortunately, however,
the therapeutic efficacy and also untoward effects of theophylline is closely related to
its concentration in the vascular system. Hence, the concept of 'therapeutic drug
monitoring' has been applied to therapy with this drug with astonishing success.
Pharmacokinetics of theophylline has been studied extensively and
several dosing guidelines have been suggested.
Theophylline and its derivatives are available as oral preparations and
injectable solutions. Oral preparations contained either theophylline or aminophylline
while injectable solutions usually contain aminophylline (equivalent to 0.8 of
theophylline). Oral preparation of theophylline are available as regular or controlled
release formulations.
Absorption
| Regular tablets |
Rapid and complete |
| |
Tmax, ~ 2 h |
| Sustained release |
May be erratic and incomplete |
| |
Presence of food may interfere with absorption
(Tmax, Cmax and AUC)
Tmax variable (4_8-h) |
Distribution
Theophylline distribute very rapidly into the peripheral tissues.
Therefore, the loading dose should be given based on total body weight.
| Vd: |
0.3 _0.7 L/kg
Greater in neonates and pregnant women. |
| Plasma protein binding: |
60% |
Elimination
Theophylline is extensively metabolized to inactive metabolites. Many
factors such as age, smoking, disease state and presence of other drugs may interfere with
clearance of the drug.
| t1/2: |
|
| |
Age |
Hours |
| |
Premature with apnea |
10 - 100 (mean 40 h) |
| |
Infants (8 - 45 wks) |
3 - 18 (mean 12 h) |
| |
Children (1 - 4 yrs) |
2 - 4 h (mean 3 h) |
| |
Children (6 - 17 yrs) |
3 - 5 h (mean 3.8 h) |
| |
Adults (18 - 73 yrs) |
5 - 10 h (mean 8 h) |
| |
Longer in acute pulmonary edema
(adults, 3-82h), hepatic cirrhosis (7-60 h) and in presence of cimetidine. |
| |
Shorter in smokers (3-6 h). |
|